1. Cymbopogon winterianus Essential Oil Attenuates Bleomycin-Induced Pulmonary Fibrosis in a Murine Model
   Lívia A. Tavares et al, 2021, Pharmaceutics CrossRef
2. Myofibroblast dedifferentiation proceeds via distinct transcriptomic and phenotypic transitions
   Sean M. Fortier et al, 2021, JCI Insight CrossRef
3. BRD4 as a Therapeutic Target in Pulmonary Diseases
   Xia Guo et al, 2023, International Journal of Molecular Sciences CrossRef
4. SB203580—A Potent p38 MAPK Inhibitor Reduces the Profibrotic Bronchial Fibroblasts Transition Associated with Asthma
   Milena Paw et al, 2021, International Journal of Molecular Sciences CrossRef
5. Influence of Shear Stress, Inflammation and BRD4 Inhibition on Human Endothelial Cells: A Holistic Proteomic Approach
   Johannes Jarausch et al, 2022, Cells CrossRef
6. Functional roles of CD26/DPP4 in bleomycin‐induced pulmonary fibrosis
   Yu Koyanagi et al, 2023, Physiological Reports CrossRef
7. Myofibroblast fate plasticity in tissue repair and fibrosis: Deactivation, apoptosis, senescence and reprogramming
   Wolfgang Merkt et al, 2021, Wound Repair and Regeneration CrossRef
8. KLF4 is a therapeutically tractable brake on fibroblast activation that promotes resolution of pulmonary fibrosis
   Loka R. Penke et al, 2022, JCI Insight CrossRef
9. Transcriptomic Evaluation of Pulmonary Fibrosis-Related Genes: Utilization of Transgenic Mice with Modifying p38 Signal in the Lungs
   Shuichi Matsuda et al, 2020, International Journal of Molecular Sciences CrossRef
10. SWAN pathway-network identification of common aneuploidy-based oncogenic drivers
    Robert R Bowers et al, 2022, Nucleic Acids Research CrossRef